Company / Working Capital per Share
BioNexus Gene Lab Corp Working Capital per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$2.74
FY2025
5-year range
$0.02 / $2.74
FY2021-FY2025
Trend
+784.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share changed +784% YoY in FY2025, a notable deviation from the 6-year average annual change of +465%.
Based on SEC 10-K filings.
2.74 in FY2025 with a 5-year CAGR of +127.6%.
Improved from $0.44 to $2.74 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +388.9%
- 5-Year CAGR
- +127.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share increased 784.4% year-over-year.
- Lowest working capital per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.74 | +784.4% |
| FY2024 | $0.31 | -30.0% |
| FY2023 | $0.44 | +1788.7% |
| FY2022 | $0.02 | -16.7% |
| FY2021 | $0.03 | -37.3% |
| FY2020 | $0.04 | +303.2% |
| FY2019 | $0.01 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026